Order Article Reprints

Sainz L, Riera P, Moya P, Bernal S, Casademont J, Díaz-Torné C, Millán AM, Park HS, Lasa A, Corominas H. Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis. Pharmaceutics. 2022; 14(9):1942. https://doi.org/10.3390/pharmaceutics14091942

Sainz, Luis, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, and Héctor Corominas. 2022. "Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis" Pharmaceutics 14, no. 9: 1942. https://doi.org/10.3390/pharmaceutics14091942

Sainz, L., Riera, P., Moya, P., Bernal, S., Casademont, J., Díaz-Torné, C., Millán, A. M., Park, H. S., Lasa, A., & Corominas, H. (2022). Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis. Pharmaceutics, 14(9), 1942. https://doi.org/10.3390/pharmaceutics14091942